U.S. Markets closed
LISTEN

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

Taro Pharmaceutical Industries Ltd. (TARO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
109.10+1.22 (+1.13%)
At close: 4:02PM EDT
People also watch
LCIIPXLSCRIUTHRPRGO
  • A
    Alexis
    Alexis
    The upside potential for TARO just got a whole lot more interesting. I started receiving notifications from awe.som_sto-cks the other week and so far they have presented interesting new trade ideas.
  • A
    Allison
    Allison
    Who says TARO isn't poised for potentially massive upward movement? check out Awe-Some.Sto-ck.s, its a pretty reliable service. of course you have to do your own due diligence, but they generally point you in the right direction.
  • M
    Mia
    Mia
    Jim cramer aint got S*%T on these guys. thestock-dork has the best plays + trading education....check it out .
  • K
    Kaylee
    Kaylee
    Who says TARO isn't poised for potentially massive upward movement? if you guys have questions you should ask awesome_sto-cks. They often respond to my emails which is helpful.
  • E
    Emily
    Emily
    Woah! I just got an awesome alert from the*stock-dork. TARO has been okay but its moving so slow.... .
  • Z
    Zo
    Zo
    taro >> LNTH
  • T
    Tom
    Tom
    Taro / Matthews India Fund

    Q: Another of your holdings is New York-listed, Israeli company Taro Pharmaceuticals. How does this fit into an India fund?

    A: Taro Pharma (TARO) is an Israeli company, but it’s owned by India’s Sun Pharma ceuticals. Sun is one of the most popular companies in India in healthcare. We feel that Sun Pharma is very expensive and 40% to 50% of its profits come from Taro. If you strip the profit and market cap from Pharma, the price-to-earnings multiple you get for Sun Pharma is like 70 or 80 times.

    It’s mostly into dermatology and it’s focused on the U.S. and Canada. There’s not much broker coverage - just one or two analysts. That’s one of the reasons the stock’s been much cheaper than other pharma companies listed in India.
  • J
    Joyce
    Joyce

    Thanks for the tip, I did some research and found more information about $TARO on http://jcharlesassets.com/opiant-pharmaceuticals/?s=TARO "rht" Investing trading stocks.

    Best MicroCap, Small Cap and Emerging Stocks to Buy - J Charles Assets
    We search for the smart new growing companies to invest in with stock deals to watch in pharmacuetical and digital verticals.
    jcharlesassets.com
  • N
    Noam
    Noam

    The🌱fate🌱of🌱the🌱books🌱solely🌱depends🌱on🌱the🌱capacity🌱of🌱the🌱readers. http://dataunion.tistory.com/11511

    Taro Pharmaceutical Industries NYSE $TARO Correlation Histogram
    X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks Sep-2016 1,000 Day Parameter 4,338 NYSE Stocks Price Analysis This stock mode of correlation coefficient is 0.8 In other words, the correlation coefficient of the other stocks
    dataunion.tistory.com
  • T
    Tom
    Tom

    https://seekingalpha.com/article/4079690-long-case-taro-pharmaceutical

    The Long Case For Taro Pharmaceutical
    TARO is a dominant generic drug manufacturer with a strong balance sheet. Trades at significant discount to peers despite much higher margins. Catalysts include
    seekingalpha.com
  • M
    Mario
    Mario

    The🌱fate🌱of🌱the🌱books🌱solely🌱depends🌱on🌱the🌱capacity🌱of🌱the🌱readers. http://dataunion.tistory.com/11511

  • b
    bab
    bab
    Any comment on the stock price?
  • M
    Mapsoda
    Mapsoda
    A break of 117.84 could move it up to 139.96 in short term. The buy rating at 9trading is set to 5.
  • B
    Becky
    Becky
    TARO has just seen the last of the selling. Looks like a potential push higher with a EPS % past 5 Y of 25.00%. have you guys heard of awesomesto-cks. i started receiving their allerts and so far i am happy.
  • T
    Tom
    Tom
    Drop in Short Interest: short interest has dropped 208,500 shares as of Feb 28 and is now dow to 2,460,100. For reference, total volume from Feb 16 to Feb 28 was 741,100 shares so short active represents around 28% of the trading activity for that period. Quite surprised shares are not trading higher. Short interest has not been this low since Aug 15, 2016 when amount was 2.44 mm shares. However, shares outstanding back then were higher prior to some of the buyback activity.
  • T
    Tom
    Tom

    Novexatin Update: further significant value creation ahead in the next 12 to 18 Months

    Novexatin developer Novabiotics taking in a new cash injection from existing investor Woodford Investment Management representing a “significant uplift” in the company’s valuation.

    The investment will be used to fund further trials in the US of its potential “blockbuster” – a brush-on anti-fungal treatment called Novexatin, which is subject to an exclusive licence and co-development agreement with US healthcare firm, Taro Pharmaceuticals.

    “Because we have got some data read outs over the next 12-18 months that is going to substantially change the valuation again,” said Mr Foulger.

    https://www.pressandjournal.co.uk/fp/business/north-of-scotland/1184866/novabiotics-raises-a-further-3million-and-looks-to-trump-fueled-ma-opportunities/

    Novabiotics raises a further £3million and looks to Trump-fueled M&A opportunities | Press and Journal
    A leading light of the north-east’s fledgling biotech sector has raised £3million from investors as it considers a trade sale inspired by President Donald Trump’s proposed changes to the US healthcare market. Aberdeen-based Novabiotics has raised the
    www.pressandjournal.co.uk
  • b
    bab
    bab
    ...any news? how is the $250m share repurchase doing? when will be finished where can the stock price go?
  • b
    bab
    bab
    ...any comment?
  • A
    Anonymous
    Anonymous

    Got a great report from http://monstatrader.com/?s=TARO about $TARO. I did have to subscribe but it was worth the time. Thank you guys for the tip! Day trading making money. Developed after years of intensive research.(it was discovered by accident.)

    MonstaTrader: OTC, NYSE, NASDAQ Stock Alerts for all Traders
    Stock alerts, stock trading, making money, sharing knowledge and always looking for the next big money maker.
    monstatrader.com
  • b
    bab
    bab
    ...ACADIAN sold 305k shares...any comment?